Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS · Delayed Price · Currency is USD
0.9400
+0.0050 (0.53%)
Inactive · Last trade price on Feb 28, 2025

Fresh Tracks Therapeutics Company Description

Fresh Tracks Therapeutics, Inc. does not have significant operations.

Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States.

Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

Fresh Tracks Therapeutics, Inc.
CountryUnited States
Founded2009
IndustryBiotechnology
SectorHealthcare
Employees4
CEOAlbert Marchio

Contact Details

Address:
2000 Central Avenue
Boulder, Delaware 80301
United States
Phone720 505 4755
Websiteir.frtx.com

Stock Details

Ticker SymbolFRTX
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS10802T2042
SIC Code2834

Key Executives

NamePosition
Albert Nicholas Marchio IIChief Executive Officer, Chief Financial Officer, Secretary and Chairman
Aaron Fox-Collis CPAVice President of Finance and Chief Accounting Officer
Sue FattorHead of Human Resource
Dr. James S. McElvain Ph.D.Interim Head of CMC Development